Clinical Trials Browser

Phase 2 × Neoplasms, Plasma Cell × Everolimus × Clear all

NCT00618345 2011-05-16

Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell